The global nerve repair market is estimated to be valued in excess of US$ 145 Mn in the year 2017 and is projected to be valued at nearly US$ 430 Mn by 2027, registering a CAGR of 11.3% over the forecast period.
Valley Cottage, NY -- (SBWIRE) -- 06/04/2019 -- A damaged nerve can result in severe sensory and motor complications, which may cause severe pain as well as malfunctioning of the appendages. In these conditions, repairing of damaged nerves becomes quite imperative. Fortunately, a range of medical products is available in the market for treating damaged nerves. Nerve protectors, nerve connectors, nerve wraps and nerve grafts are amongst some of the popular products used for nerve repairing. As these products become medically more effective, their demand continues to grow.
Future Market Insights (FMI) in its latest report titled "Nerve Repair Market: Global Industry Analysis and Opportunity Assessment 2017-2027" identifies that ageing is one of the major factors that increases possibilities of nerve damage. Occurrence of nerve damage is medically-proven to be higher amongst aged people, hence, the rising geriatric population across the globe is fueling the demand for nerve repair products. As per the FMI report, global nerve repair market will ride at an impressive CAGR of 11.3% in terms of revenue during the forecast period (2016-2027). Moreover, increasing government initiatives to spread awareness about new nerve repair treatments and availability of advanced treatment therapies is expected to boost the growth of global nerve repair market over the next couple of years.
Request to View Sample of Research Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-2680
Nerve Repair Treatment: Market Opportunities
Currently, most of the leading medical companies that manufacture nerve repair products are mainly concentrated in developed regions such as Europe and North America. Many of the developing countries including Mexico, India, Indonesia and few other countries from the Middle East are yet to witness widespread penetration of the nerve repair biomaterial products. The scope of promoting the products in such emerging markets would definitely bring in lucrative business opportunities for medical companies. Therefore, tapping emerging markets is likely to create opportunities for growth in term of sales of nerve repair products. Some of the leading medical companies are focusing on aspects such as training of physicians and marketing of their products in these developing regions. Axogen, Inc., Baxter International Inc., Stryker Corporation, Integra Lifesciences, Holdings Corp, Neurotex, Ltd. and Polyganics B.V. are some leading medical companies partaking in the growth of global nerve repairing market.
North America Nerve Repair Market to Maintain its Speedy Growth
In 2016, the nerve repair market in North America captured more than 40% share in terms of revenue. The expanding base of geriatric population and rising demand for advanced medical technology in the U.S. continues to create new market opportunities for manufacturers of nerve repair products in the region. Meanwhile, demand for nerve repair products in Japan has been overwhelmingly high in recent years and similar trends are expected to continue throughout the forecast period. In addition, nerve repair market in Japan is expected to expand at an impressive CAGR of 10.8% over the forecast period owing to increasing healthcare awareness and demand for advanced medical technology.
Request for a Customization of This Report @ https://www.futuremarketinsights.com/customization-available/rep-gb-2680
Additional Highlights of the Report Include:
Nerve graft is the most popular nerve repairing product type and is estimated to account for around 40.3% revenue share of the global market by 2017-end.
Repairing of epineural nerves is expected to remain the highest amongst all the types of nerve repair. Towards the end of the assessment period, revenue from epineural nerve repairing is estimated to reach US$ 290.3 Mn.
Hospitals will remain as the largest end user of nerve repair products and are projected to account for over 61% value share of the market by end of 2027.